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Impact of a Community-Based Hand Hygiene and Safe
Water Campaign on Knowledge and Practices of Care-
givers, Fayoum Governorate, Egypt, 2006
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Talaat1
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Egypt
2 Fayoum Health Directorate, Fayoum, Egypt
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Background: Typhoid fever remains a serious public
health problem in Egypt. In Fayoum governorate, where the
annual incidence is 0.1%, population-based studies showed
that unsafe water storage and lack of hygienic practices
are risk factors for infection. To reduce transmission, a
community-based intervention campaign was implemented
in 12 randomly selected villages in Fayoum to promote safe
water storage and hand hygiene practices. The campaign
included personal communications, village-wide meetings,
and distribution of educational materials. The objective was
to measure the impact of the campaign on the knowledge
and behavior of caregivers in the household.
Methods: Two separate random samples of households
were chosen and surveyed before and after the commu-
nity intervention. Caregivers within the selected households
were interviewed in each targeted village. Data was col-
lected on knowledge of typhoid fever symptoms, methods
of prevention and proper management of illness. Household
water storage and hand hygiene practices were observed
Results: We interviewed 942 caregivers at baseline and
conducted a ﬁnal evaluation of 764 caregivers in the same
villages. In the pre-intervention survey, 36% of caregivers
reported proper knowledge of symptoms and management
of typhoid compared to 94% following the intervention
(P < 0.0001). Similarly, the proportion of caregivers who
demonstrated proper hand washing technique increased
from 2% to 42% (P < 0.0001). The proportion of care-
givers who stored water safely increased from 3% to 19%
(P < 0.0001).
doi:10.1016/j.ijid.2008.05.1260
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Seroprevalence of Blood-Borne Infections Among Blood
Donors in Venezuela, 2001—2002
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Background: From the data collected at the Ministry of
Health from whole nation public and private blood banks
(BB) ﬁnd out the proportion of blood units discarded for
being seropositive HBV, HCV, HIV, syphilis and Trypanosoma
cruzi, and the seroprevalence of these infections among
their donors.
Methods: ELISA serological testing was done with 715,
393 donors seen at 535 blood banks between 2001 and
2002. Samples that were repeat reactive (RR) with the ELISA
underwent supplementary Western blot (WB) testing.
Results: Of the 715, 393 blood banks donors, 9,294 of
them (1.3%) were positive for syphilis (VDRL), 6,107 (0.85%)
for HBV (anti-HBc), 4,825 (0,67%) for T. cruzi, 3,859 (0.54%)
for HCV and 1, 870 (0.26%) for HIV. In the Figure a summary
of the seroprevalence of these infections, among public and
private blood banks, per year, is presented.
Conclusion: Although syphilis or Treponema pallidum
infection was the most important blood-borne disease found
in this study, the seroprevalence found is lower than oth-
ers reported in other countries in the region (e.g. Goiânia,
Brazil, 1989, 4.1%). For HBV and HCV, the seroprevalence
estimates were also similar than those found in other coun-
tries in the region (such as Río de Janeiro, Brazil, where in
2005 the anti-HBc was 2.05% and 0.79% in 2004 for HCV),
indicating high rates of infection by HBV and HCV and a per-
sistent risk of HBV and HCV transmission by transfusion. For
Chagas disease is also lower than others reported in other
countries in the region (e.g. Goiânia, Brazil, 1989, 3.3%).
Finally for HIV the found seroprevalence is similar to that
reported in Mexico (Irapuato, Mexico, 2003,0.24%). But as
seen herein, those seroprevalences are regional, and our
report is nationwide. Further epidemiological research is
expected.
doi:10.1016/j.ijid.2008.05.1261
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Background: In 1992, the World Health Assembly passed
resolution 45.17 calling for Member States, ‘‘. . .to integrate
cost-effective new vaccines, such as hepatitis B vaccine,
into national immunization programs in countries where it is
feasible. . .’’ The same year, the World Health Organization
(WHO) recommended that all countries integrate hepatitis
B vaccine (HepB) into national immunization programs by
1997. Unfortunately these goals were not met, mostly due
to ﬁnancial barriers; by 1997 only 65 Member States had
introduced HepB nationwide. Following creation of the GAVI
Alliance in 2000, ﬁnancial support was made available to
the less developed member states and Alliance partners set
new milestones calling for HepB to be introduced in these
countries 2007.
Methods: We reviewed programmatic data reported to
WHO as part of the Joint Reporting Form to determine the
number of countries that provide HepB and the coverage of
this vaccine. Data were analyzed to provide information on
program achievements over time
Results: As of 2006, 164 of 193 (85%) WHO Member States
reported having integrated HepB into their routine infant
immunization schedules. The remaining 29 countries include
those with historically low HBV prevalence and those coun-
tries gradually introducing HepB. The remaining countries
include 14 GAVI-eligible countries, of which the majority
(10) are in the WHO Africa Region (AFR). Global coverage of
three doses of hepatitis B vaccine in 2006 was 60%, compared
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with 1% in 1990. Coverage by WHO region was as follows:
AFR 49%; Region of the Americas 89%; Eastern Mediterranean
Region 78%; European region 74%; South-East Asia Region
28%; and Western Paciﬁc Region 85%
Conclusions: Tremendous progress has been made in
introduction of the ﬁrst anti-cancer vaccine into routine
immunization programs globally. The world is on track to
meet the 2007 goal of introduction of hepatitis B vaccine in
the world’s poorest countries. These achievements are likely
the result of global advocacy, decreasing vaccine prices, and
availability of resources to the poorest countries.
doi:10.1016/j.ijid.2008.05.1262
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Nonpharmaceutical Interventions Implemented by US
Cities During the 1918—1919 Inﬂuenza Pandemic
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Context: A critical question in pandemic inﬂuenza plan-
ning is the role nonpharmaceutical interventions might play
in delaying the temporal effects of a pandemic, reducing
the overall and peak attack rate, and reducing the number
of cumulative deaths. Such measures could potentially pro-
vide valuable time for pandemic-strain vaccine and antiviral
medication production and distribution. Optimally, appro-
priate implementation of nonpharmaceutical interventions
would decrease the burden on health care services and crit-
ical infrastructure.
Objectives: To examine the implementation of nonphar-
maceutical interventions for epidemic mitigation in 43 cities
in the continental United States from September 8, 1918,
through February 22, 1919, and to determine whether city-
to-city variation in mortality was associated with the timing,
duration, and combination of nonpharmaceutical interven-
tions; altered population susceptibility associated with prior
pandemic waves; age and sex distribution; and population
size and density.
Design and Setting: Historical archival research, and sta-
tistical and epidemiological analyses. Nonpharmaceutical
interventions were grouped into 3 major categories: school
closure; cancellation of public gatherings; and isolation and
quarantine.
Main Outcome Measures: Weekly excess death rate
(EDR); time from the activation of nonpharmaceutical inter-
ventions to the ﬁrst peak EDR; the ﬁrst peak weekly EDR; and
cumulative EDR during the entire 24-week study period.
There were 115 340 excess pneumonia and inﬂuenza
deaths (EDR, 500/100 000 population) in the 43 cities dur-
ing the 24 weeks analyzed. Every city adopted at least 1
of the 3 major categories of nonpharmaceutical interven-
tions. School closure and public gathering bans activated
concurrently represented the most common combination
implemented in 34 cities (79%); this combination had a
median duration of 4 weeks (range, 1—10 weeks) and
was signiﬁcantly associated with reductions in weekly EDR.
The cities that implemented nonpharmaceutical interven-
tions earlier had greater delays in reaching peak mortality
(Spearman r =−0.74, P < .001), lower peak mortality rates
(Spearman r = 0.31, P = .02), and lower total mortality
(Spearman r = 0.37, P = .008). There was a statistically
signiﬁcant association between increased duration of non-
pharmaceutical interventions and a reduced total mortality
burden (Spearman r = −0.39, P = .005)
Conclusions: These ﬁndings demonstrate a strong associ-
ation between early, sustained, and layered application of
nonpharmaceutical interventions and mitigating the conse-
quences of the 1918—1919 inﬂuenza pandemic in the United
States. In planning for future severe inﬂuenza pandemics,
nonpharmaceutical interventions should be considered for
inclusion as companion measures to developing effective
vaccines and medications for prophylaxis and treatment.
We will present both our quantitative ﬁndings and ongoing
qualitative research on the 1918—19 pandemic in the urban
United States.
doi:10.1016/j.ijid.2008.05.1263
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Background: Legionella disease (LD) is believed to be an
environmentally acquired disease, inhaled as contaminated
aerosolized water containing Legionella, and gains entry into
the lungs. Cooling towers of air conditioning systems have
been recognized as the primary source for Legionella
Objective: to determine Legionella pollution prevalence,
describe the amount of Legionella respect to temperature
in CTWs of various type of public place.
Methods: 321 cooling tower water (CTWs) from target
sites were sampled, using probability proportion (around
1/500) to size (PPS) sampling
Results: It was found that of the samples, 58.9%
(189/321) samples were observed positive with Legionella,
19.9% were isolated as over 100CFU/ml, and 0.9% even
exceeding 1000CFU/ml. Lp-1 was the most frequently iso-
lated species (155/189, 82.0%), followed by L-mic that
is at the second (44/189, 23.3%). In addition, the mean
CFU/ml of Legionella in CTWs reached its peak in July,
August and September (mean CFU/ml was 180, 170 and 170
respectively), and begins to drop gradually in October and
November, down to 39.3 and 0.33 respectively. 15.4% of
samples with exceeding 100CFU/ml were observed in a hos-
pital setting; 18.9%, 27.7%, 12.3%, and 22.7% of the samples
exceeding 100CFU/ml were from ofﬁce buildings, subway
stations, hotels, and stores respectively.
Conclusion: The problem with Legionella pollution in
CTWs, especially in subway stations and hospitals, is worry-
ing. A signiﬁcant correlation was found between the positive
rate and CFU/ml of Legionella in CTWs and air temperature.
To deal with the potential risk of LD, improved control and
prevention strategies are urgently needed.
doi:10.1016/j.ijid.2008.05.1264
